← brief for 2026-08-11 · Slowing decline

Heme-induced kallikrein-kinin system activation in hemolytic uremic syndrome

Key takeaways

In a disease called hemolytic uremic syndrome, red blood cells break apart and release a molecule called heme. This lab study looked at how heme switches on a blood-clotting and inflammation pathway that can harm the kidneys. The work was done in the lab, not tested as a treatment in people. It points to a possible target for future drugs.

Source

Paper · Kidney International · 2026-08-05
https://www.kidney-international.org/article/S0085-2538(26)00597-1/fulltext?rss=yes